TEVA
Teva Pharmaceutical Industries Ltd Earnings
$17.07
Earnings Summary
Revenue | $3891Mn |
Net Profits | $214Mn |
Net Profit Margins | 5.5% |
Teva Pharmaceutical Industries Ltd’s revenue jumped 1.54% since last year same period to $3891Mn in the Q1 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -7.99% fall in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit jumped 253.96% since last year same period to $214Mn in the Q1 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 198.62% jump in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin jumped 251.62% since last year same period to 5.5% in the Q1 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 207.18% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.63 |
EPS Estimate Current Year | 0.63 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.63 - a 36.79% jump from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.63.
Key Ratios
Earning Per Share (EPS) | 0 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Teva Pharmaceutical Industries Ltd has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-07 | 0.46 | 0.52 | 12.19% |
2025-07-30 | 0.63 | 0 | -100% |
